Showing results (201-210 of 365) with videos related to
Sort By:
Pageof 37
Nature|June 26, 1997
A new route for synthesis of dimethylsulphoniopropionate in marine algaeD A Gage, D Rhodes, K D Nolte, et al.Plant Physiology|February 5, 1998
Salinity promotes accumulation of 3-dimethylsulfoniopropionate and its precursor S-methylmethionine in chloroplastsC Trossat, B Rathinasabapathi, E A Weretilnyk, et al.The Journal of Biological Chemistry|July 20, 2001
Plants synthesize ethanolamine by direct decarboxylation of serine using a pyridoxal phosphate enzymeD Rontein, I Nishida, G Tashiro, et al.Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
A novel family-based intervention trial to improve heart health: FIT Heart: results of a randomized controlled trialLori Mosca, Heidi Mochari, Ming Liao, et al.Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancerMartin J Edelman, David R Gandara, Petr Hausner, et al.Journal of Forensic Sciences|August 8, 2013
Infrared imaging of the crime scene: possibilities and pitfallsGerda J Edelman, Richelle J M Hoveling, Martin Roos, et al.Cancer Chemotherapy and Pharmacology|May 2, 2003
Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinomaPhilip C Mack, David R Gandara, Alvin H Lau, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Phase II trial of the novel retinoid, bexarotene, and gemcitabine plus carboplatin in advanced non-small-cell lung cancerMartin J Edelman, Ruth Smith, Petr Hausner, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
CYFRA 21-1 as a prognostic and predictive marker in advanced non-small-cell lung cancer in a prospective trial: CALGB 150304Martin J Edelman, Lydia Hodgson, Paula Y Rosenblatt, et al.Cancer Immunology, Immunotherapy : CII|March 7, 2008
Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cellsMinu K Srivastava, Jacobus J Bosch, James A Thompson, et al.Pageof 37